XERIS Pharmaceuticals
USEntry
2017
Hold
1yr
Exit
2018
Who owns XERIS Pharmaceuticals?
XERIS Pharmaceuticals was owned by Merieux Equity Partners through Mérieux Innovation 1 (2014 vintage) from 2017 to 2018, exited via IPO.
Buyer identity available on Pro.
Hand-verified · updated 2026-05-07
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2018
More from Mérieux Innovation 1
Other portfolio companies in the same fund.
UK
Netherlands
FranceMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Track XERIS Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy XERIS Pharmaceuticals?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on XERIS Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue